
- /
- Supported exchanges
- / US
- / ICU.NASDAQ
LMF Acquisition Opportunities Inc (ICU NASDAQ) stock market data APIs
LMF Acquisition Opportunities Inc Financial Data Overview
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LMF Acquisition Opportunities Inc data using free add-ons & libraries
Get LMF Acquisition Opportunities Inc Fundamental Data
LMF Acquisition Opportunities Inc Fundamental data includes:
- Net Revenue: 428 K
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: -0.62
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LMF Acquisition Opportunities Inc News

SeaStar Medical Announces $4 Mln Direct Offering With Warrants In Concurrent Private Placement
(RTTNews) - SeaStar Medical Holding Corporation (ICU), a healthcare company focused on treating critical organ failure, has entered into a definitive agreement for a registered direct offering of 5,24...


SeaStar Medical raises $4 million in at-market offering
DENVER - SeaStar Medical Holding Corporation (NASDAQ:ICU), a micro-cap healthcare company with a market capitalization of $11.3 million, announced Thursday it has entered into a definitive agreement t...

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients faci...

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
DENVER, July 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients faci...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.